Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,793Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-445.2EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)18.0Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.310-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28,900,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IBBGeorge Soros 2016-09-30 Buy 0.01%$260.39 - $300.08
($284.99)
$ 269.67-5%New holding777
IBBKen Fisher 2016-09-30 Buy $260.39 - $300.08
($284.99)
$ 269.67-5%New holding1,417
IBBGeorge Soros 2016-06-30 Sold Out -0.49%$241.49 - $288.34
($269.15)
$ 269.670%Sold Out0
IBBGeorge Soros 2016-03-31 Buy 0.49%$244.04 - $338.33
($269.14)
$ 269.670%New holding67,600
IBBGeorge Soros 2015-09-30 Sold Out -0.01%$289.48 - $398
($359.64)
$ 269.67-25%Sold Out0
IBBKeeley Asset Management Corp 2015-09-30 Sold Out -0.01%$289.48 - $398
($359.64)
$ 269.67-25%Sold Out0
IBBGeorge Soros 2015-06-30 Buy 0.01%$333.61 - $383.19
($358.63)
$ 269.67-25%New holding2,400
IBBKeeley Asset Management Corp 2014-12-31 Buy 0.01%$255.27 - $308.01
($283.24)
$ 269.67-5%New holding905
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Snow, Jeffery AlexanderSenior Officer 2016-12-08Buy90,000$5.125144.53view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2016-12-08Buy10,000$0.13206453.85view
Grant, Cheryl AnnDirector, Senior Officer 2016-12-08Buy19,000$0.06447433.33view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy429$32.1736.51view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy14$32.11736.25view
Big Sky Uranium Inc.Director, Senior Officer 2016-12-08Buy2,500$1.1223875view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy400$18.951316.99view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy600$18.971315.5view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-12-08Buy15,000$0.13206453.85view
Skoda, Edward FranklinDirector 2016-12-08Buy25,000$0.23116647.83view

Press Releases about IBB :

Quarterly/Annual Reports about IBB:

    News about IBB:

    Articles On GuruFocus.com
    US Market Indexes Continue to Reach New Highs Dec 08 2016 
    Southern Company: Dividend Achiever Nearing a 5% Yield Dec 08 2016 
    Royce Funds: What's the Outlook for U.S. Small-Caps? Dec 08 2016 
    Big Insider Sell at Apple, Buy at Acushnet Dec 08 2016 
    Mason Hawkins Adds to FedEx Dec 08 2016 
    Altria Group Announces Quarterly Dividend Dec 08 2016 
    Jim Chanos Adds to Starz Dec 08 2016 
    Lam Research Increases Dividend by a Solid 50% Dec 08 2016 
    Avoid Advanced Micro Devices Dec 08 2016 
    Lululemon Is a Buy Dec 08 2016 

    More From Other Websites
    Trump's pledge to rein in drug prices takes bite out of Seattle-area biotech stocks Dec 08 2016
    The top widely held ETFs Dec 08 2016
    3 Reasons To Shrug Off Trump's Rhetoric On Drug Prices Dec 08 2016
    S&P 500 ETFs Set New Highs, But Biotechs Give Back Most Of Trump Rally Dec 07 2016
    Ovid Therapeutics CEO: US biotech best in the world Dec 07 2016
    Trump Targets Drug Prices And Apple, Seeks '5 Minutes' With Offshoring Firms Dec 07 2016
    Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers Dec 07 2016
    Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices Dec 07 2016
    President-elect Trump’s promise to bring down drug prices sends biotech and pharma ETFs slumping Dec 07 2016
    Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower Dec 07 2016
    Sonnenfeld: Trump is not a theorist, he's a pragmatist Dec 07 2016
    Drug pressure deja vu? Dec 07 2016
    This indicator says the stock market’s celebration has gone too far Dec 07 2016
    Biotech ETFs: So Much For The Trump Bounce Dec 07 2016
    Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans Dec 07 2016
    Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall Dec 07 2016
    President-elect Trump's biotech comments sharply lower biotech ETFs Dec 07 2016
    Stock Market Analysis for Week Ending 12/2/16 Dec 02 2016
    Look at Silver Miners and Some Names That Have Pulled Back Dec 02 2016
    Gundlach warns Trump trade is ‘losing steam’ and stocks have peaked Dec 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)